Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Amnesia, Anterograde D020324 2 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Toxemia D014115 3 associated lipids
Contracture D003286 3 associated lipids
Bronchial Diseases D001982 3 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Ileal Diseases D007077 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kawasaki T and Snyder F Synthesis of a novel acetylated neutral lipid related to platelet-activating factor by acyl-CoA:1-O-alkyl-2-acetyl-sn-glycerol acyltransferase in HL-60 cells. 1988 J. Biol. Chem. pmid:3422635
Heptinstall S and Bevan J How can we inhibit 5-HT-induced platelet aggregation and why should we bother? 1988 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2465956
Bodzenta-Lukaszyk A et al. Blood platelet function in patients with obliterative arteriosclerosis of the lower limbs. 1988 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2465957
Terashita Z et al. Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock. 1988 J. Cardiovasc. Pharmacol. pmid:2468048
Smith SK and Kelly RW Effect of platelet-activating factor on the release of PGF-2 alpha and PGE-2 by separated cells of human endometrium. 1988 J. Reprod. Fertil. pmid:3422322
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Bourdillat B et al. Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels. 1988 Eur. J. Pharmacol. pmid:2836213
Toyofuku T et al. Pulmonary vascular response to platelet-activating factor in conscious sheep. 1988 Am. J. Physiol. pmid:3414811
Yoshida K et al. PAF inhibitors of microbial origin. Studies on diketopiperazine derivatives. 1988 Prog Biochem Pharmacol pmid:2457219
Elstad MR et al. Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes. 1988 J. Immunol. pmid:3126231
Hanss M and Dechavanne M 48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. 1988 Thromb. Res. pmid:3126559
Nasmith PE and Grinstein S Cytosolic calcium, oxygen consumption and the intracellular pH of stimulated neutrophils. 1988 Biosci. Rep. pmid:2840131
Dulioust A et al. Immunoregulatory functions of paf-acether. I. Effect of paf-acether on CD4+ cell proliferation. 1988 J. Immunol. pmid:2961808
Acker G et al. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021. 1988 Prostaglandins pmid:3129758
Altin JG and Bygrave FL Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. 1988 Biochem. J. pmid:3128268
Yamada K et al. Parallel inhibition of platelet-activating factor-induced protein phosphorylation and serotonin release by K-252a, a new inhibitor of protein kinases, in rabbit platelets. 1988 Biochem. Pharmacol. pmid:3128296
Fernandez-Gallardo S et al. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids. 1988 Biochem. J. pmid:2848496
Levine L Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism. 1988 Mol. Pharmacol. pmid:2849046
Neuwirth R et al. Evidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells. 1988 J. Clin. Invest. pmid:3166467
Rossi AG et al. Stereospecific bioactions of 5-hydroxyeicosatetraenoate. 1988 FEBS Lett. pmid:3191990
Nakamura T et al. Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages. 1988 Eur. J. Pharmacol. pmid:2898372
Sessler CN et al. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxemia in sheep. 1988 J. Appl. Physiol. pmid:3145934
Del Monte M and Subissi A Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3149718
Hofmann B et al. Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat. 1988 Biomed. Biochim. Acta pmid:3150268
Bahr T et al. Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models. 1988 Biomed. Biochim. Acta pmid:3150272
Myers AK et al. Antagonism of PAF-induced death in mice. 1988 Prostaglandins pmid:3131837
Handley DA et al. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412. 1988 J. Pharmacol. Exp. Ther. pmid:3183958
Shalit M et al. Platelet activating factor increases expression of complement receptors on human neutrophils. 1988 J. Leukoc. Biol. pmid:2842423
Miyazawa K et al. Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species. 1988 J. Immunol. pmid:3385211
Etienne A et al. Role of neutrophils in gastric damage induced by platelet activating factor. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3244384
Archer CB et al. Actions of platelet activating factor (PAF) homologues and their combinations on neutrophil chemokinesis and cutaneous inflammatory responses in man. 1988 J. Invest. Dermatol. pmid:3385217
Taylor RR et al. Time dependence of whole blood aggregation in response to platelet activating factor (PAF). 1988 Thromb. Haemost. pmid:3388292
Powling MJ and Hardisty RM Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. 1988 Thromb. Haemost. pmid:3388294
Pirotzky E et al. Cyclosporine-induced nephrotoxicity: preventive effect of a PAF-acether antagonist, BN 52063. 1988 Transplant. Proc. pmid:3388505
Ward SG and Westwick J Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. 1988 Br. J. Pharmacol. pmid:3390650
Demopoulos CA et al. Abnormal platelet response to PAF and ADP in beta-thalassaemia. 1988 Int. J. Biochem. pmid:3391336
Christman BW et al. Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. 1988 J. Appl. Physiol. pmid:3391901
Greenberg S et al. Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. 1988 J. Biol. Chem. pmid:3392016
Etienne A et al. Possible involvement of platelet-activating factor in endotoxin-induced abortion. 1988 Prog. Clin. Biol. Res. pmid:3393560
Abraham WM The role of leukotrienes in allergen-induced late responses in allergic sheep. 1988 Ann. N. Y. Acad. Sci. pmid:2837960
Pirotzky E and Braquet P PAF-acether and kidney pathology. 1988 Prog Biochem Pharmacol pmid:3043431
Feuerstein G and Siren AL Platelet-activating factor and shock. 1988 Prog Biochem Pharmacol pmid:3043432
Mazière JC et al. PAF-acether decreases low density lipoprotein degradation and alters lipid metabolism in cultured human fibroblasts. 1988 FEBS Lett. pmid:3402608
Godfroid JJ and Heymans F Chemistry of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043433
Casals-Stenzel J and Heuer H Pharmacology of PAF antagonists. 1988 Prog Biochem Pharmacol pmid:3043436
Lima MC et al. Mediators of inflammation and antagonism of experimental pleurisy in the rat by fenspiride. 1988 Rhinol. Suppl. pmid:2907679
Rola-Pleszczynski M PAF in cellular immunology. 1988 Prog Biochem Pharmacol pmid:3043437
Baggiolini M et al. Effects of PAF on neutrophils and mononuclear phagocytes. 1988 Prog Biochem Pharmacol pmid:3043438
Ojima-Uchiyama A et al. Phospholipid analysis of human eosinophils: high levels of alkylacylglycerophosphocholine (PAF precursor). 1988 Lipids pmid:3185116
Skeaff CM and Holub BJ The effect of fish oil consumption on platelet aggregation responses in washed human platelet suspensions. 1988 Thromb. Res. pmid:3187952
Griffin KJ and Levy JV The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF). 1988 Thromb. Res. pmid:3187959
Braquet P et al. Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations. 1988 Eur. J. Pharmacol. pmid:3046952
Barr R et al. The effect of platelet activating factor on electron transport of spinach chloroplasts. 1988 Biochem. Biophys. Res. Commun. pmid:3048258
Camussi G et al. Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases. 1988 J. Exp. Med. pmid:3049910
Cahill M et al. Effect of des arginine9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture. 1988 Agents Actions pmid:3051930
Page CP et al. Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. 1988 Agents Actions Suppl. pmid:3051932
Makino S [Platelet activating factor in allergic reaction]. 1988 Arerugi pmid:3052368
Wasserman SI Platelet-activating factor as a mediator of bronchial asthma. 1988 Hosp. Pract. (Off. Ed.) pmid:3053741
Cunha FQ et al. Failure of PAF-acether to induce in vivo neutrophil migration. 1988 Agents Actions pmid:3055873
Foegh ML Eicosanoids and platelet activating factor mechanisms in organ rejection. 1988 Transplant. Proc. pmid:3059615
Chu KM et al. Local vasodilator effect of platelet activating factor in the gastric, mesenteric and femoral arteries of the dog. 1988 J. Pharmacol. Exp. Ther. pmid:3418522
Lagarde M Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. 1988 Prog. Lipid Res. pmid:3060881
Pai JK et al. Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes. 1988 Biochem. Biophys. Res. Commun. pmid:3422154
Lee TC et al. Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet-activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens. 1988 J. Biol. Chem. pmid:2828351
Nieto ML et al. Biosynthesis of platelet-activating factor in human polymorphonuclear leukocytes. Involvement of the cholinephosphotransferase pathway in response to the phorbol esters. 1988 J. Biol. Chem. pmid:2828363
Ponpipom MM et al. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. 1988 Biochem. Biophys. Res. Commun. pmid:2829894
Braquet P et al. Platelet activating factor as a mediator in cerebral ischemia and related disorders. 1988 Biomed. Biochim. Acta pmid:3073761
Hwang SB Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. 1988 J. Biol. Chem. pmid:2830276
Marquis O et al. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes. 1988 J. Pharmacol. Exp. Ther. pmid:2831350
Domingo MT et al. Presence of specific binding sites for platelet-activating factor (PAF) in brain. 1988 Biochem. Biophys. Res. Commun. pmid:2831903
Dillon PK et al. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action. 1988 Circ. Res. pmid:2832096
Arnoux B et al. Accumulation of platelets and eosinophils in baboon lung after paf-acether challenge. Inhibition by ketotifen. 1988 Am. Rev. Respir. Dis. pmid:3354991
Chau LY and Jii YJ Characterization of 3H-labelled platelet activating factor receptor complex solubilized from rabbit platelet membranes. 1988 Biochim. Biophys. Acta pmid:2838093
Thelen M et al. Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation. 1988 J. Clin. Invest. pmid:2838524
Wainwright CL et al. The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. 1988 Biomed. Biochim. Acta pmid:3248108
Dembińska-Kieć A et al. Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed. 1988 Biomed. Biochim. Acta pmid:3248109
Ostermann G et al. Structure-activity relationships of synthetic analogues of platelet-activating factor. 1988 Biomed. Biochim. Acta pmid:3248110
Droy-Lefaix MT et al. The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach. 1988 Basic Life Sci. pmid:3250539
Stahl GL et al. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. 1988 J. Pharmacol. Exp. Ther. pmid:3252036
Williams WR et al. Plates and anti-asthma drugs. 1988 Pneumonol Pol pmid:3254508
Archer CB Mediators of heat urticaria. 1988 Clin. Exp. Dermatol. pmid:3256463
Morell GP et al. Paf-acether (platelet-activating factor) and interleukin-1-like cytokine production by lipopolysaccharide-stimulated glomeruli. 1988 Clin. Immunol. Immunopathol. pmid:3257432
Pignol B et al. Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection. 1988 Transplant. Proc. pmid:3259039
Pitcock JA Morphometric studies of the renomedullary interstitial cells. 1988 Am. J. Med. Sci. pmid:3284348
Bussolino F et al. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. 1988 J. Biol. Chem. pmid:3261295
Croft KD et al. The effect of dietary fish oil and long-term salt loading on blood pressure and eicosanoid metabolism in spontaneously hypertensive rats. 1988 Clin. Exp. Pharmacol. Physiol. pmid:3271614
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Wykle RL et al. Platelet-activating factor. 1988 Meth. Enzymol. pmid:3237085
Kioumis I et al. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. 1988 Prostaglandins pmid:3237997
Sirois MG et al. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. 1988 Prostaglandins pmid:3238010
Schindler PW et al. Fluorophore-labeled ether lipids: substrates for enzymes of the platelet-activating factor cycle in peritoneal polymorphonuclear leukocytes. 1988 Anal. Biochem. pmid:3239750
Silva PM et al. Adrenalectomy exacerbates paw edema without interfering with desensitization induced by PAF-acether in rats. 1988 Braz. J. Med. Biol. Res. pmid:3240383
Fradin A et al. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'. 1988 Biochim. Biophys. Acta pmid:2848583
Fichelle J et al. Bronchospasmolytic effects of RU 42173. 1988 Fundam Clin Pharmacol pmid:3240917
Misawa M and Takata T [Effects of platelet activating factor on the bronchial musculature and vasculature in dogs]. 1988 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3241511
Yasuda K et al. Acyl type platelet-activating factor in normal rat uterus determined by gas chromatography mass spectrometry. 1988 Biomed. Environ. Mass Spectrom. pmid:3242662
Perico N et al. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney. 1988 Lab. Invest. pmid:3123798
Mallet AI Analysis of lyso-platelet activating factor by negative ion gas chromatography/mass spectrometry of the nitrobenzal acetal derivatives. 1988 Biomed. Environ. Mass Spectrom. pmid:3242671
Suzuki S et al. [Effect of a specific antagonist of platelet-activating factor, FR-900452, on proteinuria and urinary thromboxane excretion in aminonucleoside nephrotic rats]. 1988 Nihon Jinzo Gakkai Shi pmid:3244194
Colton CA and Gilbert DL An endogenous source of the superoxide anion in the central nervous system. 1988 Basic Life Sci. pmid:2854971